Episode 44: On this episode of Mostly Economics, Dean Baker talks with Tahir Amin, co-founder and CEO of I-MAK and co-author of Pharma Monopoly, about how drug patents drove up prices and blocked vaccines during the pandemic. Find out how a drug like Humira made $114 billion off patent monopolies and more.

About Tahir Amin:

Tahir Amin, LL.B., Dip. LP., is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address the systemic inequities in how medicines are developed and distributed. He has over 30 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. Tahir served on New York City Mayor Zohran Mamdani’s Transition Committee on Health.